Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors L Gandhi, DR Camidge, M Ribeiro de Oliveira, P Bonomi, D Gandara, ... Journal of clinical oncology 29 (7), 909-916, 2011 | 652 | 2011 |
Expression and distribution of renal vacuolar proton-translocating adenosine triphosphatase in response to chronic acid and alkali loads in the rat. B Bastani, H Purcell, PH Hemken, D Trigg, S Gluck The Journal of clinical investigation 88 (1), 126-136, 1991 | 248 | 1991 |
Absence of H (+)-ATPase in cortical collecting tubules of a patient with Sjogren's syndrome and distal renal tubular acidosis. EP Cohen, B Bastani, MR Cohen, S Kolner, P Hemken, SL Gluck Journal of the American Society of Nephrology 3 (2), 264-271, 1992 | 172 | 1992 |
Immunologic evidence that vacuolar H+ ATPases with heterogeneous forms of Mr= 31,000 subunit have different membrane distributions in mammalian kidney. P Hemken, XL Guo, ZQ Wang, K Zhang, S Gluck Journal of Biological Chemistry 267 (14), 9948-9957, 1992 | 117 | 1992 |
A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular … K Morota, M Nakagawa, R Sekiya, PM Hemken, LJ Sokoll, D Elliott, ... Clinical Chemistry and Laboratory Medicine 49 (4), 711-718, 2011 | 97 | 2011 |
Molecular characteristics of the novel intermediate filament protein paranemin: sequence reveals EAP-300 and IFAPa-400 are highly homologous to paranemin PM Hemken, RM Bellin, SW Sernett, B Becker, TW Huiatt, RM Robson Journal of Biological Chemistry 272 (51), 32489-32499, 1997 | 66 | 1997 |
Cellular distribution of H (+)-ATPase following acute unilateral ureteral obstruction in rats H Purcell, B Bastani, KP Harris, P Hemken, S Klahr, S Gluck American Journal of Physiology-Renal Physiology 261 (3), F365-F376, 1991 | 40 | 1991 |
Candidate epitopes for measurement of hCG and related molecules: the second ISOBM TD-7 workshop P Berger, E Paus, PM Hemken, C Sturgeon, WW Stewart, JP Skinner, ... Tumor Biology 34, 4033-4057, 2013 | 37 | 2013 |
Validation of a novel model for the early detection of hepatocellular carcinoma PM Hemken, LJ Sokoll, X Yang, J Dai, D Elliott, SH Gawel, M Lucht, ... Clinical proteomics 16, 1-9, 2019 | 30 | 2019 |
Expression of vacuolar H (+)-ATPase in mouse osteoclasts during in vitro differentiation ZQ Wang, P Hemken, D Menton, S Gluck American Journal of Physiology-Renal Physiology 263 (2), F277-F283, 1992 | 20 | 1992 |
Development of a new ARCHITECT automated periostin immunoassay NM Jeanblanc, PM Hemken, MJ Datwyler, SE Brophy, TS Manetz, R Lee, ... Clinica Chimica Acta 464, 228-235, 2017 | 15 | 2017 |
Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay PM Hemken, NM Jeanblanc, T Rae, SE Brophy, MJ Datwyler, Y Xu, ... Practical laboratory medicine 9, 58-68, 2017 | 9 | 2017 |
Role of 31k subunit in targeting renal H+ ATPase to brush border P Hemken, ZQ Wang, S Gluck Kidney Int 37, 225a, 1990 | 6 | 1990 |
Development of a new automated IL-6 immunoassay E Israeli, H Okura, B Kreutz, R Piktel, A Hadji, B Tu, Z Lin, DJ Hawksworth, ... Journal of Immunological Methods 504, 113262, 2022 | 5 | 2022 |
Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests BC Tieman, S Kovacs, MA Rodgers, A Mohaimani, S Gregory, ... Biotechniques 73 (3), 136-141, 2022 | 4 | 2022 |
Methods of prognosis and diagnosis of pancreatic cancer PM Hemken, BL Dowell, GJ Davis US Patent App. 13/828,319, 2014 | 4 | 2014 |
Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals MG Berg, E Israeli, E Quaco, GA Cloherty, PM Hemken Biotechniques 71 (1), 370-375, 2021 | 3 | 2021 |
Nucleotide sequence of paranemin reveals it is a novel intermediate filament protein PM Hemken, B Becker, RM Bellin, TW Huiatt, RM Robson MOLECULAR BIOLOGY OF THE CELL 7, 3243-3243, 1996 | 3 | 1996 |
Methods for the early detection of lung cancer BL Dowell, PM Hemken US Patent App. 13/804,639, 2014 | 2 | 2014 |
Tissue Inhibitor of Metalloproteinases-1 (TIMPP-1): Performance character of an Abbott Architect Research Use Only (RUO) assay. GJ Davis, S Chan, T Biegalski, P Hemken, B Dowell TUMOR BIOLOGY 27, 2006 | 2 | 2006 |